Skip to NavigationSkip to content

Specialists petition FDA over opioid approval process

Published on 22/03/19 at 10:27am

FDA officials have called on the federal agency to halt the approval of new narcotic painkillers.

Dr Sidney Wolfe, a former member of the FDA’s drug safety committee, and Dr Raeford Brown, the present chair of the agency’s opioid advisory committee, have launched a formal process to prevent the FDA from approving new opioids.

The doctors claim the FDA has failed to acknowledge the ongoing opioid crisis as they submitted a petition to for a process which would force the FDA to consider the impact of opioid painkillers before any more are approved.

“It is a national emergency,” Dr Wolfe said. “There’s not one opioid that’s been approved in the last 10 or 20 years that has any significant advantage in pain relief over existing ones and doesn’t just add to the probability of people getting addicted and abusing the drug.”

The FDA “can no longer be trusted” Dr Wolfe said, as he suggested their decision making process were heavily influenced in favour of the interests of the pharmaceutical industry.  

“The FDA must impose a moratorium on approval of opioids until the regulatory framework envisioned by the National Academies is in place,” Dr Wolfe and Dr Brown said in a letter top former FDA commissioner Scott Gottlieb and HHS Secretary Alex Azar. The FDA is now obliged to respond.

Louis Goss

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches